Close
Nordic 9Nordic 9

Fuji Pharma (investor - Corporate Investor)

fujipharma.jp
See something wrong or missing? Let us know
Offices:Tokyo

Fuji Pharma Co., Ltd. is a Tokyo Stock Exchange (TSE) listed, Japan-based pharmaceutical company mainly engaged in the manufacture and sale of prescription based pharmaceutical products.

Average round investment:50M USD
Average number per year:1.0
Distribution: 2018 (1)
Portfolio companies: Iceland Alvotech
Mostly invests in: Iceland Iceland (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Fuji Pharma

Name Criteria
United States Tekla Capital Management
62%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Iceland
  • Average number of deals per year: 1.0
Netherlands LSP (Life Sciences Partners)
61%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Iceland
  • Average number of deals per year: 1.4
France Seventure Partners
61%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Iceland
  • Average number of deals per year: 1.9
United Kingdom Novator Partners
60%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Iceland
  • Average number of deals per year: 2.3
United States Adjuvant Capital
58%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Sweden AP3
58%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Sweden AP4 - Fjärde AP-fonden
58%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Sweden Bengt Julander
58%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
France Biocodex
58%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
United States Boxer Capital
58%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Top